Search
Search Results
##search.searchResults.foundPlural##
-
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
4080PDF: 2012HTML: 275 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1017PDF: 551HTML: 223 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1379PDF: 549HTML: 296 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2456PDF: 1032HTML: 1659Fig 1: 212Tab I: 238Cover Letter: 235 -
Pseudo-differentiation syndrome
1441PDF: 697HTML: 10878Figure 1: peripheral blood showing myeloblasts with auer rods: 139Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 123Figure 3: CXR showing pulmonary infiltartes with consolidation: 147Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 130Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 129 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2235PDF: 1038HTML: 4096Cover Letter: 242Figure 1: 256Figure 2: 249Table 1: 230 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4620PDF: 1786HTML: 1230 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
797PDF: 919PDF Supp. Files: 90HTML: 254 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2156PDF: 803HTML: 3255 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1670PDF: 686HTML: 1437 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1470PDF: 854HTML: 8674Fig 3 Savini: 201Fig 2 Savini: 206Fig 1 Savini Chest TC: 205Author letter to referees: 213 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1285PDF: 625HTML: 2907ATRA induced Reactive Hemophagocytosis: A Case Report: 220 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4925PDF: 1860HTML: 2866Untitled: 251 -
-
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1026PDF: 557HTML: 741 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4910PDF: 1900HTML: 2189 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1364PDF: 1084HTML: 429 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4160PDF: 1197HTML: 2107Fig.1: 228Fig. 2: 123Table 1: 224Table2: 243Table 3: 223 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4174PDF: 1299HTML: 2118Table 1: 219 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1659PDF: 1105HTML: 478 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1603PDF: 1070HTML: 140 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
923PDF: 538HTML: 242Suppl. Files: 342







